image
Madrigal Pharmaceuticals, Inc. MDGL
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 288.58
-4.66 %
$ 6.29 B
Market Cap
-11.53
P/E
BALANCE SHEET
641 M ASSETS
76.67%
Growth Rates
1Year 76.67%
3Years 30.68%
5Years 5.70%
7Years 47.99%
10Years 21.00%
235 M LIABILITIES
42.40%
Growth Rates
1Year 42.40%
3Years 71.02%
5Years 94.53%
7Years 74.37%
10Years 17.70%
405 M EQUITY
105.35%
Growth Rates
1Year 105.35%
3Years 19.09%
5Years -3.20%
7Years 41.10%
10Years 23.50%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Madrigal Pharmaceuticals, Inc.
image
Current Assets 637 M
Cash & Short-Term Investments 634 M
Receivables 0
Other Current Assets 3.15 M
Non-Current Assets 3.27 M
Long-Term Investments 0
PP&E 3.27 M
Other Non-Current Assets 0
Current Liabilities 119 M
Accounts Payable 28 M
Short-Term Debt 1.05 M
Other Current Liabilities 89.5 M
Non-Current Liabilities 117 M
Long-Term Debt 117 M
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2001
ASSETS
Cash & Cash Equivalents 99.9 331.5 36.3 54.0 46.7 483.7 191.5 40.5 35.0 46.0 48.5 81.5 30.1 31.3 44.2 52.0 115.6 33.7 23.8 42.7 36.1 0
Short Term Investments 534.2 27.2 234.1 230.1 392.3 426.3 42.9 21.4 31.6 51.7 43.0 19.1 9.7 19.7 0 21.5 0 13.1 38.2 82.2 40.2 0
Receivables 0 0 0 0 0 0 0 0 7.33 K 0 0 0 0 0.1 0 16.0 0 0 0 0 0 0
Inventory 0 0 0 0 0 0 0 0 7.33 K 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 3.1 2.6 2.7 2.0 2.3 3.0 1.0 0.7 50 K 1.7 1.5 1.6 1.1 0.4 0.8 1.7 1.4 0.8 0.9 1.1 0.8 0
Total Current Assets 637.3 361.4 271.7 285.2 440.2 485.2 192.0 41.2 67.8 99.3 92.2 101.4 40.3 51.5 44.6 91.2 117.0 47.6 63.0 126.0 77.1 0
PP&E 3.3 1.2 1.6 1.8 1.9 0.2 0.3 2.95 K 0.4 1.0 1.6 1.2 1.4 2.2 4.0 5.9 5.6 6.1 8.1 4.8 3.2 0
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 0 0 0 0 0 0 0 54 0 0.3 1.4 0.5 0.6 0.4 0.4 0.1 76 K 1.1 0.1 1.2 82 K 0
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2.8
Total Assets 640.5 362.6 273.3 287.0 442.1 485.4 192.3 41.2 68.2 100.7 95.2 103.0 42.3 54.1 48.9 97.3 122.6 54.8 71.2 132.0 80.4 2.8
LIABILITIES
Accounts Payable 28.0 23.8 21.4 1.0 1.2 2.5 1.9 0.8 0.1 3.1 6.6 5.7 3.5 1.9 4.0 3.3 2.5 2.6 3.4 2.9 0.2 0
Short Term Debt 1.1 0.6 0.8 0.6 0.6 0 0 0 48.6 9.3 9.5 8.0 4.2 0.2 1.3 4.3 2.4 2.3 1.9 0.5 0 0
Other Current Liabilities 89.5 91.5 54.6 44.9 23.3 6.0 8.1 4.0 0.6 18.5 16.1 9.9 7.4 10.0 6.6 13.1 10.5 6.1 8.7 9.0 2.9 0
Total Current Liabilities 118.5 115.9 76.8 46.6 25.1 8.4 10.1 4.8 17.8 30.9 32.2 23.5 15.1 16.7 16.5 33.3 20.8 11.5 14.5 12.9 3.5 0
Long Term Debt 116.7 49.3 0.4 0.5 0.4 0 0 0 0 4.7 13.9 4.5 12.4 11.7 0.8 8.3 2.8 3.2 4.3 1.2 0 0
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 0 0 0 26 K (0.8) (114.4) (74.2) 0 0 0 0 0
Other Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 41.8 0 0 0 0
Total Liabilities 235.2 165.2 77.2 47.0 25.5 8.4 10.1 4.8 17.8 35.5 46.1 28.0 27.6 30.6 24.0 156.0 97.8 56.5 18.7 14.1 3.5 29 K
EQUITY
Common Stock 2 K 2 K 2 K 2 K 2 K 2 K 1 K 1.2 K 14 K 11 K 9 K 7 K 5 K 4 K 3 K 3 K 3 K 2 K 2 K 3 K 3 K 1 K
Retained Earnings (1 336.3) (962.7) (667.3) (425.5) (223.2) (139.3) (106.5) (75.3) (706.2) (637.6) (551.4) (461.2) (398.4) (351.1) (313.6) (392.7) (300.1) (236.6) (179.3) (110.4) (64.5) 0
Other Accumulative Comprehensive Income/Loss 0.5 32 K 80 K 47 K 0.2 (0.3) 31 K 25.4 K 4 K 4 K 17 K 2 K 3 K 3 K (16.0) 15 K (11.5) 2 K (7.3) (10.6) (2.8) 0
Total Equity 405.3 197.4 196.1 240.0 416.6 477.0 182.3 36.4 50.4 65.1 49.1 75.1 14.8 23.5 24.9 (58.8) 24.9 (1.7) 52.5 118.0 76.9 2.7
Total Liabilities and Equity 640.5 362.6 273.3 287.0 442.1 485.4 192.3 41.2 68.2 100.7 95.2 103.0 42.3 54.1 48.9 97.3 122.6 54.8 71.2 132.0 80.4 2.8
SHARES OUTSTANDING
Common Shares Outstanding 18.7 17.1 16.5 15.4 15.4 14.8 12.2 5.2 0.2 2.8 2.0 1.7 1.3 1.2 1.0 1.0 0.9 0.6 0.6 0.5 0.6 0.3 83.7 K